These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2440174)

  • 21. Agglutination antibody responses to Trypanosoma gambiense homogenate in mice treated with dextran sulfate 500 and carrageenan.
    Oka M; Osaki H; Furuya M; Ito Y; Oka Y
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):173-81. PubMed ID: 6171951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression of humoral and cell-mediated responses in calves associated wtih inoculation of Mycoplasma bovis.
    Bennett RH; Jasper DE
    Am J Vet Res; 1977 Nov; 38(11):1731-8. PubMed ID: 931157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyclonal activation of rat splenic lymphocytes after in vivo administration of Mycoplasma pulmonis and its relation to in vitro response.
    Williamson JS; Davis JK; Cassell GH
    Infect Immun; 1986 May; 52(2):594-9. PubMed ID: 3486159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
    Davis JK; Davidson M; Schoeb TR
    Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum antibody does not account for differences in the severity of chronic respiratory disease caused by Mycoplasma pulmonis in LEW and F344 rats.
    Simecka JW; Davis JK; Cassell GH
    Infect Immun; 1989 Nov; 57(11):3570-5. PubMed ID: 2807538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions.
    Talkington DF; Fallon MT; Watson HL; Thorp RK; Cassell GH
    Microb Pathog; 1989 Dec; 7(6):429-36. PubMed ID: 2622331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors in resistance to and recovery from M. pulmonis-induced arthritis in mice.
    Taylor G; Taylor-Robinson D
    Ann Rheum Dis; 1977 Jun; 36(3):232-8. PubMed ID: 879860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies as probes for antigens of Mycoplasma pulmonis.
    Rose FV; Barile MF; Cebra JJ
    Adv Exp Med Biol; 1983; 162():319-26. PubMed ID: 6191534
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of some immunomodulators on the delayed-type hypersensitivity to nonviable Mycoplasma pulmonis in mice.
    Kishima M; Kuniyasu C; Nakagawa M
    Nihon Juigaku Zasshi; 1984 Dec; 46(6):889-91. PubMed ID: 6521151
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative serology of Mycoplasma pulmonis.
    Haller GJ; Boiarski KW; Somerson NL
    J Infect Dis; 1973 Mar; 127():Suppl:S38-42. PubMed ID: 4570126
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis.
    Lai WC; Pakes SP; Ren K; Lu YS; Bennett M
    J Immunol; 1997 Mar; 158(6):2513-6. PubMed ID: 9058780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential subunit vaccine against Mycoplasma pulmonis purified by a protective monoclonal antibody.
    Lai WC; Bennett M; Pakes SP; Murphree SS
    Vaccine; 1991 Mar; 9(3):177-84. PubMed ID: 1828319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological cross-reactivity of porcine reference antisera to Mycoplasma hyopneumoniae, M. flocculare, M. hyorhinis and M. hyosynoviae indicated by the enzyme-linked immunosorbent assay, complement fixation and indirect hemagglutination tests.
    Freeman MJ; Armstrong CH; Sands-Freeman LL; Lopez-Osuna M
    Can J Comp Med; 1984 Apr; 48(2):202-7. PubMed ID: 6372971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant properties of polysaccharides: effect of iota-carrageenan, pectic acid, pectin, dextran and dextran sulphate on the humoral immune response in the rat.
    Nicklin S; Atkinson HA; Miller K
    Food Addit Contam; 1988; 5(4):573-80. PubMed ID: 2461322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
    Rose FV; Cebra JJ
    Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against Mycoplasma pulmonis infection by genetic vaccination.
    Lai WC; Bennett M; Johnston SA; Barry MA; Pakes SP
    DNA Cell Biol; 1995 Jul; 14(7):643-51. PubMed ID: 7626224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Mycoplasma pulmonis by fluorogenic nuclease polymerase chain reaction analysis.
    Loganbill JK; Wagner AM; Besselsen DG
    Comp Med; 2005 Oct; 55(5):419-24. PubMed ID: 16270897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immune response of calves given Mycoplasma bovis antigens.
    Carroll EJ; Bennett RH; Rollins M; Jasper DE
    Can J Comp Med; 1977 Jul; 41(3):279-86. PubMed ID: 907904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of mice against vaginal colonisation by Mycoplasma pulmonis.
    Taylor-Robinson D; Furr PM
    J Med Microbiol; 1994 Mar; 40(3):197-201. PubMed ID: 8114070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunosuppressive effect of Mycoplasma meleagridis on nonreplicating antigens.
    Ortiz AM; Yamamoto R; Benedict AA; Mateos AP
    Avian Dis; 1981; 25(4):954-63. PubMed ID: 6175300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.